New tech has potential to tackles manufacturing bottlenecks in blood cancer treatment
Researchers from the University of South Australia (UniSA) have developed a new technique to enhance Chimeric antigen receptor (CAR) T-cell therapy for leukaemia and other blood cancers.
Read More